Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Thyroid Neoplasms 1Thymoma 1Small Cell Lung Carcinoma 1Sarcoma 1Mesothelioma 1Lymphoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 2belinostat 2Surveys and Questionnaires 2Radiosurgery 2Nivolumab 2Magnetic Resonance Spectroscopy 2Cisplatin 2trastuzumab deruxtecan 1trametinib 1tislelizumab 1tipifarnib 1temsirolimus 1spartalizumab 1selpercatinib 1romidepsin 1repotrectinib 1regorafenib 1pazopanib 1larotrectinib 1durvalumab 1cemiplimab 1cc-486 1alectinib 1Valproic Acid 1Transurethral Resection of Prostate 1Tamoxifen 1Sunitinib 1Specimen Handling 1Sirolimus 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Doxepin × Sarcoma × Clear all
NCT02062632 2019-10-01

Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy

Mayo Clinic

Phase 2 Terminated
5 enrolled 4 charts
GastrointestinalHead & NeckLymphoidOther solid neoplasmSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lymphoma, Mesothelioma, Sarcoma, Thymoma, Thyroid Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡